Cost–Utility Analysis of Mindfulness-Based Cognitive Therapy VersusAntidepressant Pharmacotherapy for Prevention of Depressive Relapse in aCanadian Context: Analyse coût-utilité de la thérapie cognitive basée sur lapleine conscience contre la pharmacothérapie antidépressive pour prévenir larechute de la dépression en contexte canadien

摘要

Patients suffering from major depressive disorder (MDD) experience impairedfunctioning and reduced quality of life, including an elevated risk ofepisode return. MDD is associated with high societal burden due to increasedhealthcare utilization, productivity losses, and suicide-related costs,making the long-term management of this illness a priority. The purpose ofthis study is to evaluate the cost-effectiveness of mindfulness-basedcognitive therapy (MBCT), a first-line preventative psychological treatment,compared to maintenance antidepressant medication (ADM), the currentstandard of care.